GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Renal | AB, MB, ON, QC | Recruiting
SPARTA
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)
Apollomics Inc.
Start Date: September 27, 2017

NCT #: NCT03175224

SPONSOR: Apollomics Inc.

INFO: https://clinicaltrials.gov/ct2/show/NCT03175224?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=27

CONTACT:  Vivian Huey // clinops@apollomicsinc.com

OTHER CANADIAN CENTRES: 

JGH (Montreal)                                                                                               
Cross Cancer Institute (Edmonton)                                                            
McGill University Health Centre (Montreal)                                           
Princess Margaret Hospital (Toronto).                                                      
Cancer Care Manitoba (Winnipeg)
 

Renal | ON | Recruiting
LIBERATE
Liquid Biopsy Evaluation and Repository Development at Princess Margaret.
Dr. Lillian Siu (PMH) Toronto
Start Date: August 3, 2017

NCT #: NCT03702309

SPONSOR: University Health Network

INFO:  https://clinicaltrials.gov/ct2/show/NCT03702309?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=18

CONTACT: 

Celeste Yu // 416-946-4501 x 5281

Renal | MB, NB, ON, QC, SK | Active, not recruiting
MK-3475-564/ KEYNOTE-564
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy.
Study Director: Medical Director Merck Sharp & Dohme LLC
Start Date: June 9, 2017

NCT #: NCT03142334

SPONSOR: Merck

INFO: https://clinicaltrials.gov/ct2/show/NCT03142334?term=KEYNOTE-564&draw=2&rank=1

OTHER CANADIAN CENTRES:

1. CancerCare Manitoba (Winnipeg, MB)                                    
2. Dr. Leon Richard Oncology Centre (Moncton, NB)                               
3. William Osler Health System (Brampton, ON)                        
4. Juravinski Cancer Centre (Hamilton, ON)                                
5. London Regional Cancer Program (London, ON)                   
6. Lakeridge Health (Oshawa, ON)                                               
7. Niagara Health System (St. Catherine's, ON)                       
8. CIUSSS du Saguenay-Lac-St-Jean (Chicoutimi, QC)              
9. CISSS-CA Hotel Dieu de Levis (Lévis, QC)                            
10. CIUSSS de l Est de L Ile de Montrea (Montreal QC)        
11. St-Jerome Medical Research Inc  (St-Jerome QC)           
12. Allan Blair Cancer Centre (Regina, SK)                                  
13. Saskatoon Cancer Centre (Saskatoon, SK)

 

Testes | MB, NL, NS, ON, QC | Recruiting
AGCT1531
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Dr. A. L Frazier
Start Date: May 8, 2017

NCT #: NCT03067181

SPONSOR: Children's Oncology Group in Collaboration with the National Cancer Institute (NCI)

INFO: https://clinicaltrials.gov/ct2/show/NCT03067181?term=testicular+carcinoma&recrs=abf&cntry=CA&draw=2&rank=1

OTHER CANADIAN CENTRES:

1. Alberta Children's Hospital (Calgary)

Dr. V.A. Lewis

403-220-6898; research4kids@ucalgary.ca   

2. University of Alberta Hospital

Dr. S.J. McKillop

780-407-8798; pedsoncologyresearch@ahs.ca                                                      

3. British Columbia Children's Hospital (Vancouver)

Dr. D.B. Dix                

604-875-2345 x 6477                                                                                                 

4. CancerCare Manitoba (Winnipeg)

Dr. A. Chopek

866-561-1026; ctu_web@cancercare.mb.ca                                                        

5. Janeway Child Health Centre (St. John's, NL)

Dr. L.A. Goodyear

866-722-1126                                                                                                                 

6. IWK Health Centre (Halifax)

Dr. C. Erker                                                          

902-470-8520; Research@iwk.nshealth.ca                                                              

7. McMaster Children's Hospital (Hamilton, ON)

Dr. U.H. Athale                        

905-521-2100                                                                                                                

8. Kingston Health Sciences Centre

Dr. L. Wheaton                                              

613-549-6666; cc-clinicaltrials@kgh.kari.net                                                         

9. Children's Hospital (London, ON)

Dr. S.M. Zelcer                                            

519-685-8306                                                                                                                           

10. Children's Hospital of Eastern Ontario (Ottawa)

Dr. D.L. Johnson              

613-737-7600                                                                                                                   

11. Odette Cancer Centre - Sunnybrook Health Sciences Centre (Toronto)   

Dr. A.L. Covens

416-480-5000                                                           

12. Hospital for Sick Children (Toronto)

Dr. F. Shaikh                                                    

416-813-7654; ask.CRS@sickkids.ca                                                                     

13. University Health Network - Princess Margaret Hospital (Toronto)   

Dr. R.J. Hamilton

416-946-4501; clinical.trials@uhn.on.ca                           

14. The Montreal Children's Hospital of the MUHC (Montreal)                 

Dr. S. B. Abish

514-412-4445; info@thechildren.com

15. Centre Hospitalier Universitaire Sainte-Justine (Montreal)

514-345-4931; yvan.samson@umontreal.ca

16. Centre Hospitalier Universitaire de Quebec (Quebec)

Dr. B. Michon 

418-525-4444

Prostate | ON | Recruiting
432-2015
Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer
Dr. Charles Cunningham
Start Date: December 15, 2016

NCT #: NCT02844647

SPONSOR: Sunnybrook Health Sciences Centre

INFO:  https://clinicaltrials.gov/ct2/show/NCT02844647

CONTACT:  416-489-6100 ext 83655

Prostate | ON, QC | Recruiting
PR19
A Randomized Phase II Trial Evaluating High Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Dr. Eric Vigneault (CHUQ) & Dr. Gerar Morton (Odette Cancer Centre)
Start Date: November 6, 2016

NCT#:  NCT02960087

INFO: https://clinicaltrials.gov/ct2/show/NCT02960087

CONTACT: 

(418) 691-5264

(416) 480-6165

Prostate | BC | Recruiting
H15-02103
Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer
Dr. Juanita Crook
Start Date: May 1, 2016

NCT #:  NCT02692105

SPONSOR: British Columbia Cancer Agency 

INFO: https://clinicaltrials.gov/ct2/show/NCT02692105

CONTACT:  250 712 3958

Bladder | AB, QC | Active, not recruiting
CheckMate 274
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Start Date: March 22, 2016

NCT #: NCT02632409

SPONSOR: BMS

INFO:  https://clinicaltrials.gov/ct2/show/NCT02632409?term=checkmate+274&draw=2&rank=1

CONTACT: Bristol-Myers Squibb in Collaboration with Ono Pharmaceutical Co. Ltd.

OTHER CANADIAN CENTRES:

1. Cross Cancer Institute (Edmonton, AB)

2. McGill University Health Centre (Montreal, QC)

3. Hopital Fleurimont (CHUS) (Sherbrook, QC)

4. Centre Hospitalier De L'Universite De Montreal (Montreal, QC)

 

Bladder | AB, BC, MB, NS, ON, QC | Recruiting
CBCIS
Canadian Bladder Cancer Information System
Dr. Wassim Kassouf & Dr. Peter Black (Co-Chairs)
Start Date: January 1, 2015

SPONSOR: Bladder Cancer Canada

INFO: https://bladdercancercanada.org/en/canadian-bladder-cancer-information-system/

CONTACT: camilla.tajzler@muhc.mcgill.ca

OTHER CANADIAN CENTRES:
1. McGill University Health Centre (Montreal): Dr. W. Kassouf                                                                          
2. Univesity of British Columbia (Vancouver): Dr. P. Black                                               
3. Cross Cancer Centre (Edmonton): Dr. A. Fairey                                                            
4. Alberta Health Services (Calgary): Dr. Nimira Alimohamed                                                       
5. Manitoba CancerCare (Winnipeg): Dr. J. Graham                                                        
6. Western University (Longon): Dr. J. Izawa                                                                       
7. McMaster University (Hamilton): Dr. B. Shayegan                                                      
8. University Health Network (Toronto): Dr. G. Kulkarni                                                     
9. Ottawa Hospital: Dr. R. Breau                                                                                           
10. Centre hospitalier d’université de Montréal (CHUM) (Montreal): Dr. JB. Lattouf                     
11. Centre hospitalier d'université du Québec (CHUQ) (Québec): Dr. M. Lodde               
12. Capital Health (Halifax): Dr. R. Rendon                                                                            
13. Kingston General Hospital (Kingston): Dr. R. Siemens                                                   
14. Université de Sherbrooke (Sherbrooke): Dr. C. Jeldres
15. Trillium Health Partners (Mississauga): Dr. Andrew Feifer

Renal | AB, BC, MB, NS, ON, QC | Recruiting
CKCis
Canadian Kidney Cancer information system
Dr. Rodney Breau & Dr. Naveen Basappa (Co-Chairs)
Start Date: January 1, 2011

SPONSOR: KCRNC

INFO: https://www.kcrnc.ca/ckcis/

CONTACT:  CT.Solutions@pm.me

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy